|
Media Contact
Annette Ballou
Email
216.658.3999
|
|
|
|
|
Newsroom > News
|
|
|
Nervomatrix, an Israeli medical device company, has raised a $3.5 million series A led by Everett Partners. The company has selected Akron for its North American sales and marketing headquarters. Nervomatrix's neurostimulation device, which noninvasively alleviates low back pain, has received 510(k) approval and sales have commenced
Click here to read more from MedCity News.
|
|
|
|
|